Abstract
Heme oxygenase (HO) is the rate-limiting enzyme in degrading heme to form bilirubin, and thus serves as an ideal therapeutic target for preventing neonatal jaundice. Understanding the regulatory pathways of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
